Company’s proprietary AI technology allows for expansion into predictive monitoring and new disease profiling
The New England Journal of Medicine article cites AI and its potential for increased healthcare efficiency and insights
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2023 / Dr. Waqaas Al-Siddiq, Founder and CEO of Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a leading medical diagnostic and consumer healthcare technology company, today commented on contributions of artificial intelligence (AI) and machine learning and its transformative nature for healthcare.
As stated in The New England Journal of Medicine, March 30, 2023 article entitled, Artificial Intelligence in Medicine, “Tools that utilize AI have come into increasing use in analyzing and interpreting large research databases containing information ranging from laboratory findings to clinical data. All these tools offer the potential for increased efficiency and may, perhaps, render insights that are difficult to attain with more traditional data-analysis methods.”